Guyasuta Investment Advisors’s ResMed RMD Stock Holding History

Guyasuta Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$324K	Buy	1,660 +5	+0.3%	+$1.04K	0.02%	224
2026 Q1	$372K	Buy	1,655 +4	+0.2%	+$997	0.02%	204
2025 Q4	$398K	Buy	1,651 +4	+0.2%	+$1.02K	0.02%	188
2025 Q3	$451K	Buy	1,647 +3	+0.2%	+$819	0.03%	175
2025 Q2	$424K	Buy	1,644 +3	+0.2%	+$716	0.03%	172
2025 Q1	$367K	Buy	1,641 +4	+0.2%	+$934	0.02%	178
2024 Q4	$374K	Buy	1,637 +3	+0.2%	+$722	0.02%	189
2024 Q3	$399K	Buy	1,634 +10	+0.6%	+$2.23K	0.02%	182
2024 Q2	$279K	Hold	1,624	–	–	0.02%	193
2024 Q1	$279K	Hold	1,624	–	–	0.02%	196
2023 Q4	$279K	Buy	1,624 +4	+0.2%	+$615	0.02%	196
2023 Q3	$240K	Buy	1,620 +6	+0.4%	+$1.08K	0.02%	212
2023 Q2	$353K	Buy	1,614 +3	+0.2%	+$669	0.03%	180
2023 Q1	$353K	Buy	1,611 +3	+0.2%	+$651	0.03%	182
2022 Q4	$335K	Buy	1,608 +3	+0.2%	+$659	0.03%	178
2022 Q3	$350K	Buy	1,605 +3	+0.2%	+$683	0.03%	164
2022 Q2	$336K	Buy	1,602 +86	+6%	+$18.3K	0.03%	201
2022 Q1	$368K	Buy	1,516 +3	+0.2%	+$726	0.03%	210
2021 Q4	$394K	Buy	1,513 +2	+0.1%	+$519	0.03%	212
2021 Q3	$398K	Buy	1,511 +3	+0.2%	+$820	0.03%	201
2021 Q2	$372K	Buy	1,508 +2	+0.1%	+$420	0.03%	204
2021 Q1	$292K	Buy	1,506 +3	+0.2%	+$602	0.02%	209
2020 Q4	$319K	Buy	1,503 +3	+0.2%	+$598	0.03%	191
2020 Q3	$257K	Hold	1,500	–	–	0.02%	194
2020 Q2	$288K	Hold	1,500	–	–	0.03%	178
2020 Q1	$221K	Hold	1,500	–	–	0.03%	175
2019 Q4	$232K	Hold	1,500	–	–	0.02%	197
2019 Q3	$203K	Buy	+1,500	New	+$197K	0.02%	200

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Guyasuta Investment Advisors's RMD Position: Q2 2026 in Review

Guyasuta Investment Advisors increased its ResMed (RMD) stake by 0.3% in Q2 2026, buying an estimated $1.04K and bringing the position to 1,660 shares worth $324K. The position accounts for 0.02% of the portfolio, ranked #224.

Guyasuta Investment Advisors first reported a position in RMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $451K in Q3 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Guyasuta Investment Advisors held 1,660 shares of ResMed worth $324K as of Q2 2026.
Guyasuta Investment Advisors bought 5 ResMed shares in Q2 2026, an estimated $1.04K.
ResMed made up 0.02% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #224 holding.
Guyasuta Investment Advisors first reported a position in ResMed in Q3 2019 and has held it in 28 quarters since.
Guyasuta Investment Advisors's ResMed position peaked at $451K in Q3 2025.
448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.